Journal Article

DZNE-2022-00296

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders.

Gilley, J. ; Jackson, O. ; Pipis, M. ; Estiar, M. A. ; Al-Chalabi, A. ; Danzi, M. C. ; van Eijk, K. R. ; Goutman, S. A. ; Harms, M. B. ; Houlden, H. ; Iacoangeli, A. ; Kaye, J. ; Lima, L. ; Genomics, Q. S. (Collaboration Author) ; Ravits, J. ; Rouleau, G. A. ; Schüle, R.DZNE* ; Xu, J.DZNE* ; Züchner, S. ; Cooper-Knock, J. ; Gan-Or, Z. ; Reilly, M. M. ; Coleman, M. P.

2021
eLife Sciences Publications Cambridge

This record in other databases:    

Please use a persistent id in citations: doi:10.7554/eLife.70905

Abstract: SARM1, a protein with critical NADase activity, is a central executioner in a conserved programme of axon degeneration. We report seven rare missense or in-frame microdeletion human SARM1 variant alleles in patients with amyotrophic lateral sclerosis (ALS) or other motor nerve disorders that alter the SARM1 auto-inhibitory ARM domain and constitutively hyperactivate SARM1 NADase activity. The constitutive NADase activity of these seven variants is similar to that of SARM1 lacking the entire ARM domain and greatly exceeds the activity of wild-type SARM1, even in the presence of nicotinamide mononucleotide (NMN), its physiological activator. This rise in constitutive activity alone is enough to promote neuronal degeneration in response to otherwise non-harmful, mild stress. Importantly, these strong gain-of-function alleles are completely patient-specific in the cohorts studied and show a highly significant association with disease at the single gene level. These findings of disease-associated coding variants that alter SARM1 function build on previously reported genome-wide significant association with ALS for a neighbouring, more common SARM1 intragenic single nucleotide polymorphism (SNP) to support a contributory role of SARM1 in these disorders. A broad phenotypic heterogeneity and variable age-of-onset of disease among patients with these alleles also raises intriguing questions about the pathogenic mechanism of hyperactive SARM1 variants.

Keyword(s): Adult (MeSH) ; Aged (MeSH) ; Alleles (MeSH) ; Amyotrophic Lateral Sclerosis: genetics (MeSH) ; Amyotrophic Lateral Sclerosis: metabolism (MeSH) ; Animals (MeSH) ; Armadillo Domain Proteins (MeSH) ; Cytoskeletal Proteins (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Mice (MeSH) ; Middle Aged (MeSH) ; Motor Neuron Disease: genetics (MeSH) ; Motor Neuron Disease: metabolism (MeSH) ; NAD+ Nucleosidase: metabolism (MeSH) ; Nicotinamide Mononucleotide: metabolism (MeSH) ; ALS ; NADase ; SARM1 ; genetics ; genomics ; human ; neuroscience ; risk allele ; Armadillo Domain Proteins ; Cytoskeletal Proteins ; SARM1 protein, human ; Nicotinamide Mononucleotide ; NAD+ Nucleosidase

---

Contributing Institute(s):

1. Functional Neurogeriatrics (AG Maetzler)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2021

---

Database coverage:
; ; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record

---